CARB-X global partnership headed toward developing an innovative vaccine against potentially deadly Staphylococcus aureus bacteria that could be a “game
IBT CEO Dr. M. Javad Aman will discuss the development of a multi-component toxoid vaccine for S. aureus and the
IBT Bioservices Transforms Identity, Elevates Focus on Contract Research Services
CARB-X global partnership headed toward developing an innovative vaccine against
IBT CEO Dr. M. Javad Aman will discuss the development
Subscribe to the IBT Bioservices Tech Talk list and receive periodic updates on industry news and IBT Bioservices products and services.
